B Group Inc. Invests $5 Million in Bright Minds Biosciences' Epilepsy Drug Pipeline

On May 15, 2026, B Group Inc. disclosed a new investment of approximately $5.43 million into Bright Minds Biosciences (NASDAQ:DRUG), acquiring 67,500 shares as part of its portfolio strategy. The stake represents about 4% of the firm's reportable assets under management and highlights confidence in DRUG’s pipeline targeting neurological disorders.

By Jonathan Ponciano, The Motley Fool Fri, May 22, 2026 at 12:51 AM GMT+3 4 min read · Yahoo Finance · May 21, 2026, 21:51 UTC

Tickers: $DRUG

Topics: biotech epilepsy drug pipeline institutional investment SEC filing

Read the full article at Yahoo Finance

More World news

Aline Accounting Partners Secures $206 Million in Financing Led by Square Nine Capital PR Newswire · November 12, 2026, 18:00 UTC
Egan-Jones November 2026 Report Shows Soft CLO Issuance Amid Improving Credit Metrics PR Newswire · November 12, 2026, 18:00 UTC
Blackbaud Reports Third Quarter Revenue Growth and Strategic AI Integration Motley Fool · November 12, 2026, 17:53 UTC
Sprott Physical Copper Trust Reports Significant Increase in Q3 Net Income Seeking Alpha · November 12, 2026, 17:51 UTC
Federal Reserve to Designate October 2027 Meeting as Non-Voting Strategic Session CNBC · November 12, 2026, 17:48 UTC
Sprott Physical Platinum and Palladium Trust Reports Q3 Net Income Decline Seeking Alpha · November 12, 2026, 17:47 UTC
Nvidia CEO Jensen Huang Resigns Amidst Market Volatility and AI Sector Shifts Motley Fool · November 12, 2026, 17:45 UTC
Honda to Transition CR-V Lineup to All-Hybrid Powertrains by 2027 Seeking Alpha · November 12, 2026, 17:43 UTC
Sprott Physical Silver Trust USD Reports Q3 Net Income of $425.83 Million Seeking Alpha · November 12, 2026, 17:44 UTC
Nvidia CEO Jensen Huang Resigns Amid Allegations of Personal Misconduct and China Export Control Concerns The Verge · November 12, 2026, 17:44 UTC